| Course | PUBH 8502 Scholar-Practitioner Inquiry II |
|---|---|
| Week | Week 10 |
| Paper type | Settledness statement |
| Length | About 550 words, 4 pages |
| Format | APA 7 student paper |
| School | Walden University |
| Program | PhD in Public Health |
| Updated | October 2026 |
Free sample paper for PUBH 8502 Week 10
Settled, Disputed, Untried: A Settledness Statement Sorting What the Evidence Says About Raising Chlamydia Retest Rates Before a Composite Clinic Chooses What to Trial
Student Name
Walden University
PUBH 8502: Scholar-Practitioner Inquiry II
Instructor Name
Month Day, Year
Settled, Disputed, Untried: A Settledness Statement Sorting What the Evidence Says About Raising Chlamydia Retest Rates Before a Composite Clinic Chooses What to Trial
Purpose
This statement sorts the main claims from the Harbor Street review into three lists. Settled claims are supported consistently across studies of reasonable quality. Disputed claims have conflicting or weak evidence. Untried claims concern questions no included study examined. The nurse manager can act on settled claims, should test disputed ones and should know that untried questions are where a local trial would add something new.
Settled
Retesting after chlamydia treatment is uncommon in many settings. A national laboratory analysis found retesting among roughly 22% of men and 38% of nonpregnant women after a positive result (Hoover et al., 2012). This finding agrees with Harbor Street's own matched records.
Reinfection after treatment is common enough to justify retesting, as the 47 studies in one review put the median reinfection share among treated females at 13.9% (Hosenfeld et al., 2009).
Some active follow-up raises return compared with advice alone. Across the controlled studies in a systematic review, mailed kits and most reminder strategies increased rescreening (Guy et al., 2012). The size of the gain varies, but its direction is consistent.
Disputed
How much reminders help is disputed. Reminder studies produced effects ranging from none to large, and the review's authors did not pool them. The contradiction analysis suggested that delivery failure, access and sender identity may explain the spread, but this remains an explanation, not a finding.
Whether incentives help is disputed but leans negative. A randomized comparison found that a $20 payment at the return visit did not clearly raise return over a brief recommendation (Malotte et al., 2004), and the review reported a similar result.
Whether higher retesting leads to fewer complications is disputed because no included study measured it. Studies stop at the retest itself.
Untried
No included study tested reminders combined with confirming contact details at the treatment visit, the change Harbor Street's records most suggest.
No included study offered mailed kits only to clients living far from the clinic. The kit studies offered them to everyone, so their effect among clients with long journeys is unknown.
No included study focused on walk-in clinics, where clients may never have booked a visit and may not expect a follow-up call.
What This Means for the Decision
The settled claims justify trying some form of active follow-up. The disputed claims mean Harbor Street cannot predict how large the effect of reminders will be and should measure it. The untried claims are exactly where a local trial would add to knowledge, which strengthens the case for the two-part trial recommended earlier.
How the Lists Could Change
A claim moves between lists as evidence arrives. If a well-designed trial at a walk-in clinic reported a clear reminder effect once contact details were confirmed, that claim would move from untried toward settled. If Harbor Street's own trial found no gain from kits among distant clients, the kit claim would become disputed rather than promising. The statement should be revised whenever the review is updated. Each revision would note the date, the new study and which claim moved, so readers can see how the evidence base has shifted over time rather than finding a list that silently changed.
References
Guy, R., Hocking, J., Low, N., Ali, H., Bauer, H. M., Walker, J., Klausner, J. D., Donovan, B., & Kaldor, J. M. (2012). Interventions to increase rescreening for repeat chlamydial infection. Sexually Transmitted Diseases, 39(2), 136-146. https://doi.org/10.1097/OLQ.0b013e31823ed4ec
Hoover, K. W., Tao, G., Nye, M. B., & Body, B. A. (2012). Suboptimal adherence to repeat testing recommendations for men and women with positive chlamydia tests in the United States, 2008-2010. Clinical Infectious Diseases, 56(1), 51-57. https://doi.org/10.1093/cid/cis771
Hosenfeld, C. B., Workowski, K. A., Berman, S., Zaidi, A., Dyson, J., Mosure, D., Bolan, G., & Bauer, H. M. (2009). Repeat infection with chlamydia and gonorrhea among females: A systematic review of the literature. Sexually Transmitted Diseases, 36(8), 478-489. https://doi.org/10.1097/OLQ.0b013e3181a2a933
Malotte, C. K., Ledsky, R., Hogben, M., Larro, M., Middlestadt, S., St. Lawrence, J. S., Olthoff, G., Settlage, R. H., & Van Devanter, N. L. (2004). Comparison of methods to increase repeat testing in persons treated for gonorrhea and/or chlamydia at public sexually transmitted disease clinics. Sexually Transmitted Diseases, 31(11), 637-642. https://doi.org/10.1097/01.olq.0000143083.38684.9d
PUBH 8502 Week 10 instructions, in plain terms
Settledness or state-of-the-evidence assignments ask students to summarize what their review has established, what remains uncertain and what has not been studied. Prompts usually require claims grouped by strength of evidence, each supported by citations, and a short discussion of what the pattern means for practice or research. Instructors expect clear criteria for each category. Statements that call everything uncertain, or that treat a single study as settled, tend to lose credit because the exercise is about matching confidence to evidence. Many also ask how the categories might change as new studies appear.
How the PUBH 8502 Week 10 example is put together
The statement opens by defining settled, disputed and untried and saying what each means for the manager. Three settled claims follow, each with its evidence: low retesting nationally, common reinfection, and a consistent benefit of active follow-up. Three disputed claims cover the size of reminder effects, the value of incentives and whether more retesting reduces complications. Three untried claims name questions no included study addressed. A section explains what the pattern means for the decision, and a final section describes how claims would move between lists as new evidence appears. Every settled and disputed claim carries a citation, while untried claims are supported by noting which included studies did not address them. The statement stays within two pages so the manager can read it in one sitting.
Reading the PUBH 8502 Week 10 rubric
Graders typically assess clear criteria, accurate placement of claims, supporting citations, and a useful link to the decision at hand. Defining the categories before using them earns credit. Placing a claim as disputed because results vary, rather than because evidence is absent, shows careful distinction. Identifying untried questions that match the local setting demonstrates how a review can point to new knowledge. Explaining how claims could move between lists shows awareness that evidence changes. Statements whose categories visibly shape a recommendation tend to score higher than those that summarize without consequence. Short paragraphs, one claim each, make the statement easy to scan and to revise. Graders also look for a closing section that says how the lists will be kept current as the review is updated, since a statement of this kind ages quickly.
PUBH 8502 Week 10 help: mistakes that cost marks
Write down what settled, disputed and untried will mean for your review before sorting anything. Go through your findings one claim at a time and ask how consistent and how strong the support is. Be careful not to call a claim settled because one good study supports it. Look for questions that matter in your setting but that no study tested; those are your untried claims. Explain what the sorting means for the decision. If you are unsure where a claim belongs, we can draft a sample statement from your review's findings. Revisit the lists whenever the review is updated.
Get a PUBH 8502 Week 10 example written to your instructions
Share your evidence table, your appraisal notes and a first guess at what is settled, then include the Week 10 prompt with its rubric. The statement sorts each claim into settled, disputed or untried, with support shown and what would move it. No charge on the first, back within 24 to 48 hours; the review sorted here is composite.
More PUBH 8502 papers and PhD in Public Health samples
- PUBH 8502 Week 1: Discussion Post
- PUBH 8502 Week 2: Search Strategy
- PUBH 8502 Week 3: Inclusion Rules
- PUBH 8502 Week 4: Pilot Search Log
- PUBH 8502 Week 5: Evidence Table
- PUBH 8502 Week 6: Critical Appraisal
- PUBH 8502 Week 7: Applicability Memo
- PUBH 8502 Week 8: Peer Critique
- PUBH 8502 Week 9: Contradiction Analysis
- PUBH 8502 Week 11: Review draft
- PUBH 8501 Week 10: Problem Statement
- PUBH 8410 Week 10: Attribution Memo
- PUBH 8211 Week 10: Peer Critique
- PUBH 8132 Week 10: Ethics Memo
PUBH 8502 Week 10 questions, answered
Where can I find a free PUBH 8502 Week 10 sample paper?
The whole Week 10 settledness statement is reproduced above, sorting claims about chlamydia retesting.
What claims are settled?
That retesting is uncommon, reinfection is frequent, and active follow-up raises return over advice alone.
What claims are disputed?
How much reminders help, whether incentives help, and whether more retesting reduces complications.
What is untried?
Reminders combined with contact confirmation, kits offered by distance, and any intervention at a walk-in clinic.
How could a claim move between lists?
A well-designed new trial, including the clinic's own, could move an untried or disputed claim toward settled.